Flunarizine is a calcium-channel blocking agent used in neurology, primarily for the prevention of migraine and treatment of certain vestibular disorders. In Hong Kong, it is available as a prescription pill in strengths of 5 mg and 10 mg. The medication is classified as a prescription (Rx) product and is regulated by the Hong Kong Department of Health.
Flunarizine blocks voltage-gated calcium channels, especially the L-type channels that regulate calcium influx into nerve cells. By reducing intracellular calcium, the drug stabilises neuronal excitability and diminishes the release of excitatory neurotransmitters such as glutamate. This action helps to prevent the cascade of events that lead to migraine attacks and can improve vestibular function in patients with balance disorders. The drug is well absorbed after oral administration, reaches peak plasma concentrations within 2-3 hours, and has a relatively long half-life (approximately 18 hours), allowing once-daily dosing.
These indications are based on clinical studies and the prescribing information approved by the Hong Kong Department of Health.
Evidence from peer-reviewed studies suggests that flunarizine may have utility in:
Off-label use requires medical supervision and individualized risk assessment.
If interaction data for a specific medication are limited, patients should inform their healthcare provider of all concurrent drugs, supplements, and herbal products.
Dosing must be individualized by a healthcare provider based on the patient’s clinical profile.
This article provides educational information about flunarizine and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
Yes, flunarizine can be combined with beta-blockers, but physicians often monitor blood pressure and heart rate because both agents can lower these parameters. Adjustments may be needed based on the individual’s response.
Drowsiness is a common early side effect. It usually improves after a few weeks; however, if it persists or interferes with daily activities, discuss dose reduction or an alternative prophylactic option with your doctor.
For mild hepatic impairment (Child-Pugh A), flunarizine can be used with standard dosing, but liver function should be monitored regularly. More severe impairment requires dose adjustment or avoidance.
Flunarizine primarily acts as a calcium-channel blocker, while topiramate is an anticonvulsant that modulates sodium channels and GABA receptors. Their side-effect profiles differ; flunarizine is more associated with sedation and weight gain, whereas topiramate can cause paresthesia and cognitive slowing.
Yes, flunarizine is a prescription medication; bring the original prescription label and a copy of the doctor's note, especially when crossing borders. Check the destination country's regulations for any restrictions on calcium-channel blockers.
There are no specific dietary restrictions, but excessive alcohol may intensify drowsiness. Maintaining a balanced diet can help mitigate modest weight gain that some patients experience.
Symptoms include rash, itching, swelling (especially of the face or throat), severe dizziness, or difficulty breathing. Seek emergency medical care immediately if these arise.
Flunarizine is marketed under its chemical name, and generic formulations are available from several local pharmaceutical suppliers. The active ingredient and strength remain the same.
Most clinicians recommend continuing preventive therapy for at least 6-12 months after achieving satisfactory control, followed by a gradual taper to assess whether the medication can be safely discontinued.
Flunarizine does not typically interfere with standard blood tests, but it can raise liver enzyme levels in rare cases; thus, periodic liver function monitoring is advised.
